Perrigo Company plc (PRGO)

Healthcare · Drug Manufacturers Specialty Generic · NYSE

Perrigo Company plc (PRGO) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.78B, a trailing price-to-earnings ratio of 5.1 and a free-cash-flow yield of 8.2%. Over the most recent reported fiscal year, revenue declined 2.8% and free cash flow per share fell 41.1%.

Market cap	$1.78B
Trailing P/E	5.1
FCF yield	8.2%
Revenue growth (YoY)	-2.8%
EPS growth (YoY)	+7.0%
FCF/share growth (YoY)	-41.1%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live PRGO data on Nama Insights →

Recent Congressional trades

Perrigo Company plc trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Susan M Collins	Senate	Buy	$15,001 - $50,000	—
Richard L. Hanna	House	Buy	$1,001 - $15,000	Sep 26, 2016
James M Inhofe	Senate	Sell	$50,001 - $100,000	—
Richard L. Hanna	House	Buy	$50,001 - $100,000	Aug 11, 2016
Richard L. Hanna	House	Buy	$15,001 - $50,000	Jul 29, 2016
James M Inhofe	Senate	Buy	$50,001 - $100,000	—
Richard L. Hanna	House	Buy	$100,001 - $250,000	May 14, 2016
Alan S. Lowenthal	House	Buy	$1,001 - $15,000	Mar 11, 2016
Lamar Smith	House	Sell	$1,001 - $15,000	Apr 8, 2015
Susan M Collins	Senate	Buy	$1,001 - $15,000	—
K. Michael Conaway	House	Buy	$1,001 - $15,000	Mar 5, 2014